BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18846772)

  • 1. [Change in the survival of Cuban AIDS patients with tuberculosis in the Highly Active Antiretroviral Therapy (HAART) era].
    Reyes-Corcho A; Capo de Paz V; Díaz-Jidy M; Pérez-Avila J; Bouza-Jiménez Y
    Invest Clin; 2008 Sep; 49(3):309-20. PubMed ID: 18846772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients.
    García de Olalla P; Martínez-González MA; Caylà JA; Jansà JM; Iglesias B; Guerrero R; Marco A; Gatell JM; Ocaña I;
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1051-7. PubMed ID: 12546112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
    Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal observation of an interferon gamma-released assay (T-SPOT.TB) for Mycobacterium tuberculosis infection in AIDS patients on highly active antiretroviral therapy.
    Zhang LF; Liu XQ; Zuo LY; Li TS; Deng GH; Wang AX
    Chin Med J (Engl); 2010 May; 123(9):1117-21. PubMed ID: 20529548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
    Chan KC; Wong KH; Lee SS
    HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
    Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
    Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus.
    López-Gatell H; Cole SR; Hessol NA; French AL; Greenblatt RM; Landesman S; Preston-Martin S; Anastos K
    Am J Epidemiol; 2007 May; 165(10):1134-42. PubMed ID: 17339383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan.
    Tseng SH; Jiang DD; Hoi HS; Yang SL; Hwang KP
    Am J Trop Med Hyg; 2009 Apr; 80(4):675-7. PubMed ID: 19346398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
    Antinori S; Ridolfo A; Fasan M; Magni C; Galimberti L; Milazzo L; Sollima S; Adorni F; Giuliani G; Galli M; Corbellino M; Parravicini C
    HIV Med; 2009 Jan; 10(1):6-11. PubMed ID: 19125961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
    Sungkanuparph S; Chakriyanuyok T; Butthum B
    J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
    Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
    Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis of CMV retinitis among patients with AIDS in Serbia.
    Dujić M; Jevtović Dj; Salemović D; Ranin J; Brmbolić B; Djurković-Djaković O
    Biomed Pharmacother; 2008 Sep; 62(7):443-7. PubMed ID: 18243635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.
    Breen RA; Smith CJ; Bettinson H; Dart S; Bannister B; Johnson MA; Lipman MC
    Thorax; 2004 Aug; 59(8):704-7. PubMed ID: 15282393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of tuberculosis in patients with AIDS in Puerto Rico: morbidity and survival, 1981-1998.
    Pérez-Perdomo R; Pérez-Cardona CM; Suárez-Pérez E
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):713-8. PubMed ID: 10949322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for the survival of patients with AIDS cholangiopathy.
    Ko WF; Cello JP; Rogers SJ; Lecours A
    Am J Gastroenterol; 2003 Oct; 98(10):2176-81. PubMed ID: 14572564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-related mortality among tuberculosis patients in The Netherlands, 1993-2001.
    Haar CH; Cobelens FG; Kalisvaart NA; van Gerven PJ; van der Have JJ
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):1038-41. PubMed ID: 17918662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improved prognosis in HIV/AIDS related multi-drug resistant tuberculosis patients treated with highly active antiretroviral therapy].
    Waisman JL; Palmero DJ; Alberti FA; Güemes Gurtubay JL; Francos JL; Negroni R
    Medicina (B Aires); 2001; 61(6):810-4. PubMed ID: 11808419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.